Ulrich D Jentschura

Ulrich D Jentschura

Missouri University of Science and Technology, USA

Combined Therapy: Interferones, Digestive Enzymes, Immune Boosters

Abstract:

The talk describes a novel ansatz for cancer treatment, based on the combined action of
natural interferones, digestive enzymes used in Asian medicine, and generic immune boost-
ers. The idea is to combine the cell-growth-inhibitor properties of natural interferones (e.g.,
withaferin-A) with generic immune boosters (e.g., high doses of vitamin C on a level ex-
ceeding RDA by a factor of at least six, and other ingredients). As already observed by
physicians in the 1800s, a “natural” boosting of the immune system due to influenza in-
fections often is able to stimulate an increased immune response against cancer cells which
are otherwise effecctively “hiding” from the immune system. Similar observations had been
made by Imhotep, the physician treating Pharaoh Djoser, when he deliberately infected the
Pharaoh's tumor using a pultice, following an incision, about 2600BC. The third ingredient,
the digestive enzymes, serve to “accelerate the convergence" of the therapy, by stimulating
fast removal of the killed cancer cells from the human body. One enzyme of particular effec-
tiveness is serratiopeptidase, which is used by the Chinese silk worm in order to dispose of
its cocoon with a time frame of about 15 minutes. The enzyme is routinely used with good
effect in Asian medicine. The application of the therapy is recorded for a case study; results
have been discussed in [U. D. Jentschura, J. Cancer Therapy 9, 156 (2018)]. The therapy
ansatz could supplement established approaches based on surgery and chemotherapy, and
be useful in the context of cancer prevention.